143 related articles for article (PubMed ID: 30206932)
1. Cytoplasmic p27
Calvayrac O; Nowosad A; Cabantous S; Lin LP; Figarol S; Jeannot P; Serres MP; Callot C; Perchey RT; Creff J; Taranchon-Clermont E; Rouquette I; Favre G; Pradines A; Manenti S; Mazieres J; Lee H; Besson A
J Pathol; 2019 Jan; 247(1):60-71. PubMed ID: 30206932
[TBL] [Abstract][Full Text] [Related]
2. p27
Podmirseg SR; Vosper J; Hengst L
J Pathol; 2019 May; 248(1):3-5. PubMed ID: 30549261
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer.
Kelly-Spratt KS; Philipp-Staheli J; Gurley KE; Hoon-Kim K; Knoblaugh S; Kemp CJ
Oncogene; 2009 Oct; 28(41):3652-62. PubMed ID: 19648963
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro.
Serres MP; Zlotek-Zlotkiewicz E; Concha C; Gurian-West M; Daburon V; Roberts JM; Besson A
Oncogene; 2011 Jun; 30(25):2846-58. PubMed ID: 21317921
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line.
Wang S; Yan-Neale Y; Fischer D; Zeremski M; Cai R; Zhu J; Asselbergs F; Hampton G; Cohen D
Oncogene; 2003 Sep; 22(40):6204-13. PubMed ID: 13679859
[TBL] [Abstract][Full Text] [Related]
7. Loss of p27Kip¹ promotes metaplasia in the pancreas via the regulation of Sox9 expression.
Jeannot P; Callot C; Baer R; Duquesnes N; Guerra C; Guillermet-Guibert J; Bachs O; Besson A
Oncotarget; 2015 Nov; 6(34):35880-92. PubMed ID: 26416424
[TBL] [Abstract][Full Text] [Related]
8. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line.
Sato N; Fukui T; Taniguchi T; Yokoyama T; Kondo M; Nagasaka T; Goto Y; Gao W; Ueda Y; Yokoi K; Minna JD; Osada H; Kondo Y; Sekido Y
Int J Cancer; 2007 Feb; 120(3):543-51. PubMed ID: 17096327
[TBL] [Abstract][Full Text] [Related]
9. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.
Besson A; Gurian-West M; Chen X; Kelly-Spratt KS; Kemp CJ; Roberts JM
Genes Dev; 2006 Jan; 20(1):47-64. PubMed ID: 16391232
[TBL] [Abstract][Full Text] [Related]
10. Chronic p27
Patki M; McFall T; Rosati R; Huang Y; Malysa A; Polin L; Fielder A; Wilson MR; Lonardo F; Back J; Li J; Matherly LH; Bepler G; Ratnam M
Sci Rep; 2018 Oct; 8(1):16006. PubMed ID: 30375484
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27
Kim C; Jeong DE; Heo S; Ji E; Rho JG; Jung M; Ahn S; Kim YJ; Kim YS; Nam SW; Kulkarni RN; Lee KB; Lee EK; Kim W
J Pathol; 2018 Oct; 246(2):231-243. PubMed ID: 30014466
[TBL] [Abstract][Full Text] [Related]
12. miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer.
Fernandez S; Risolino M; Mandia N; Talotta F; Soini Y; Incoronato M; Condorelli G; Banfi S; Verde P
Oncogene; 2015 Jun; 34(25):3240-50. PubMed ID: 25151966
[TBL] [Abstract][Full Text] [Related]
13. RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer.
Calvayrac O; Pradines A; Raymond-Letron I; Rouquette I; Bousquet E; Lauwers-Cances V; Filleron T; Cadranel J; Beau-Faller M; Casanova A; Milia J; Favre G; Mazières J
Clin Cancer Res; 2014 Dec; 20(24):6541-50. PubMed ID: 25320360
[TBL] [Abstract][Full Text] [Related]
14. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
[TBL] [Abstract][Full Text] [Related]
15. p27
Bencivenga D; Caldarelli I; Stampone E; Mancini FP; Balestrieri ML; Della Ragione F; Borriello A
Cancer Lett; 2017 Sep; 403():354-365. PubMed ID: 28687353
[TBL] [Abstract][Full Text] [Related]
16. p27(Kip1) signaling: Transcriptional and post-translational regulation.
Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
[TBL] [Abstract][Full Text] [Related]
17. Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma.
Ho WC; Pikor L; Gao Y; Elliott BE; Greer PA
J Biol Chem; 2012 May; 287(19):15458-65. PubMed ID: 22427650
[TBL] [Abstract][Full Text] [Related]
18. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.
Denicourt C; Saenz CC; Datnow B; Cui XS; Dowdy SF
Cancer Res; 2007 Oct; 67(19):9238-43. PubMed ID: 17909030
[TBL] [Abstract][Full Text] [Related]
19. RHOB expression controls the activity of serine/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers.
Calvayrac O; Pradines A; Favre G
Small GTPases; 2018 Jul; 9(4):339-344. PubMed ID: 27676292
[TBL] [Abstract][Full Text] [Related]
20. Post-translational regulation of the tumor suppressor p27(KIP1).
Vervoorts J; Lüscher B
Cell Mol Life Sci; 2008 Oct; 65(20):3255-64. PubMed ID: 18636226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
